Philippine Red Cross clarifies it is not into selling vaccines

Marje Pelayo   •   May 18, 2021   •   531

MANILA, Philippines — The Philippine Red Cross (PRC) issued a clarification regarding reports by news outlets saying the humanitarian organization would be selling  COVID-19 vaccines developed by American pharmaceutical firm Moderna to the public.

The news reports quoted PRC Chairman Senator Richard Gordon to have said that those who cannot wait for the free jabs from the government may pay the organization P3,500 for two doses of Moderna vaccine.

“To set the record straight, PRC Chairman Richard Gordon never announced that the Red Cross is selling vaccines. He stressed the need to act fast and vaccinate as many people as we can,” explained PRC governor Ma.Carissa Coscolluela.

Coscolluela noted what Gordon meant was, the PRC has procured Moderna COVID 19 vaccines and intends to vaccinate Red Cross members and donors, who are also PRC members and are willing to bear the cost of the vaccines.

The overall cost, Coscolluela said, would be US$26.83 (P1,284) per dose plus an administration fee that covers cost for syringes, gloves, PPEs, meals and allowances of PRC doctors and nurses, and other essential expenses related to the vaccination.

“The PRC is a humanitarian organization and is not in the business of selling any vaccines. It does not charge for anything that it got free,” Coscolluela stressed.

Over 682K Moderna vaccine doses arrive in Philippines

Robie de Guzman   •   November 23, 2021

MANILA, Philippines – Another batch of Moderna COVID-19 vaccine doses arrived in the country Tuesday morning, the National Task Force (NTF) against COVID-19 said.

The NTF said the shipment contains a total of 682,360 vaccine doses procured by the Philippine government.

Since February, the country has received over 130 million doses of various COVID-19 vaccine brands.

The latest shipment is expected to be used in the inoculation of booster doses for senior citizens and selected immunocompromised individuals.

As of November 22, a total of 33,847,741 individuals have been fully vaccinated against coronavirus disease, according to government data.

Over 3.5 million more doses of Sinovac vaccine arrive in PH

Robie de Guzman   •   November 17, 2021


MANILA, Philippines – Another batch of Sinovac COVID-19 vaccine doses has arrived in the Philippines, the National Task Force (NTF) against COVID-19 said Wednesday.

The shipment containing a total of 3,530,400 doses of Sinovac vaccine landed at the Ninoy Aquino International Airport Terminal 2 at past 7 a.m.

The NTF said the latest batch was procured by the government through the Asian Development Bank.

The Philippines is set to launch a new phase in its vaccination drive with the rollout of booster shots for healthcare workers and other eligible sectors as part of efforts to widen the immunization coverage.

So far, more than 31 million of the country’s 109 million population have been fully immunized.

The national government has been eyeing to vaccinate up to 70 million people to achieve population protection against COVID-19.

DOST to start clinical trial for mix-and-match COVID-19 vax

Maris Federez   •   November 12, 2021

MANILA, Philippines — The Department of Science and Technology (DOST) is set to start the clinical trial for mix and match COVID-19 vaccines.

The trial will be conducted in the cities of Manila, Marikina, Muntinlupa, Dasmarinas, and Davao.

The DOST said it is awaiting the final approval of the Food and Drug Administration (FDA) to conduct the trial.

DOST Undersecretary for Research and Development Rowena Guevara said the agency is currently holding training and virtual site initiation visits in areas where the clinical study will take place.

“Sa kasalukuyan, hindi pa tayo nagre-recruit dahil inaantay namin ang final approval ng FDA bago tayo magsimula ng pagbabakuna. Ngunit ang project team ay handa na po,” Guevara said.

The DOST are looking for unvaccinated individuals aged 18 and above to participate in the trial.

Pregnant women and those who have contracted the disease can no longer join the study.

Those with comorbidities may join the trial as long as they are able to seek clearance from the doctors that they are medically stable.

The participants in the trial will be divided into three groups with the first group to be vaccinated with Sinovac vaccines for the first and second dose.

The second group will be injected with Sinovac for the first dose and other brands such as Pfizer-BioNTech, Moderna, AstraZeneca, or Sputnik V for the second dose.

The third dose, on the other hand, will receive Sinovac for their first and second dose, and another brand as a booster shot.

“Iyong isang grupo na pag-aaral ay bibigyan ng Sinovac at Sinovac lang. Tapos iyong pangalawang grupo naman, marami sila bibigyan ng Sinovac bilang first dose, tapos 250 bibigyan ng Pfizer-Biontech, Moderna, AztraZeneca, o Sputnik V bilang second dose. Iyong pangatlong grupo naman ang mayroon third dose o booster. Sinvoac ang ibibigay na una at second dose tapos Pfizer, Moderna, AstraZeneca o Sputnik V ang gagamitin na third dose,” Guevara said. —/mbmf (from the report of UNTV Correspondent Aileen Cerrudo)


The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel) (General inquiries)


UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.